SCHEMBL13060703

SCHEMBL13060703

CCc1cccc(CN(CCN(C)C)Cc2ccccc2C#N)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CALM1 P0DP23 1/20 0.45
CAMKK2 Q96RR4 1/20 0.45
TSHR P16473 3/20 0.41
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 2/20 0.41
SQLE Q14534 1/20 0.36
NR3C1 P04150 1/20 0.36
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
BCHE P06276 2/20 0.34
ACHE P22303 1/20 0.34
TAS2R14 Q9NYV8 1/20 0.34
TP53 P04637 1/20 0.34
POLB P06746 1/20 0.34
SLC6A4 P31645 3/20 0.33
SLC6A2 P23975 2/20 0.33
USP2 O75604 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13060704 0.82 CALM1 (0.49) CALM1CAMKK2TSHRKDM4EALDH1A1
SCHEMBL13061102 0.81 CALM1 (0.64) CALM1CAMKK2TSHRKDM4EALDH1A1
SCHEMBL13061136 0.81 CALM1 (0.48) CALM1CAMKK2TSHRKDM4EALDH1A1
SCHEMBL13060693 0.81 CALM1 (0.48) CALM1CAMKK2TSHRKDM4EALDH1A1
SCHEMBL13061031 0.80 CYP2D6 (0.49) CALM1CAMKK2TSHRKDM4EALDH1A1
SCHEMBL13061083 0.79 CALM1 (0.49) CALM1CAMKK2TSHRKDM4EALDH1A1
SCHEMBL13061134 0.78 CALM1 (0.55) CALM1CAMKK2TSHRKDM4EALDH1A1
SCHEMBL13061121 0.77 SLC6A3 (0.46) CALM1CAMKK2TSHRKDM4EALDH1A1
SCHEMBL13061111 0.77 CALM1 (0.44) CALM1CAMKK2TSHRKDM4EALDH1A1
SCHEMBL13060673 0.75 CALM1 (0.50) CALM1CAMKK2TSHRKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7851637-B2 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners INFINITY PHARMACEUTICALS, INC. (US) 2010-12-14 US disclosed